Micro
Aftermath
Active
Morgan Stanley boosts GILD outlook on updated biopharma models
Activity declining — narrative losing relevance.
Score
0.2
Velocity
▲ 0.0
Articles
5
Sources
1
Top Movers
| Ticker | Sector | Change |
|---|---|---|
| GILD | Healthcare | +10.9% |